Global Cancer Screening Market Report and Forecast 2024-2032

Global Cancer Screening Market Outlook

The global cancer screening market is expected to grow in the forecast period of 2024-2032 at a CAGR of 9%.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increasing Focus on Early Detection and Prevention of Cancer Aiding the Growth of Cancer Screening Industry

The cancer screening industry is being aided by the surging cancer cases across the world. The development of superior imaging to identify the cancerous tissues of different cancer types is also propelling the market growth. As cancer is one of the leading causes of death worldwide, the demand for early detection and cure of the chronic disease is rising. Screenings are increasingly used to detect cancers and to reduce the death rates from the illness. The Asia Pacific region is expected to witness significant growth due to the rising cancer cases attributed to unhealthy lifestyles and the rising consumption of tobaccos and other carcinogenic products. Moreover, the increasing penetration of technological advancements and the improving healthcare infrastructure, along with the rising awareness of various chronic diseases in the emerging economies, such as India, China, Indonesia, and Brazil, among others, are lubricating the market growth.

Geographically, North America holds a significant share of the market due to the surging cancer cases in the country as well as increasing research and development (R&D) to diagnose and treat cancer effectively. Moreover, the advancement of biotechnology and the presence of global players in the region are further fuelling the market growth. The Control of Centre of Diseases and Prevention (CDC) of the United States offers various programs, such as National Breast and Cervical Early Cancer Detection Program (NBCCEDP), through which cost-effective screening is offered to the patients. Such initiatives are lubricating the industry growth.

Cancer Screening: Market Segmentation

Cancer screening is a test that can aid in detecting cancer at an early stage before symptoms appear. It decreases the chance of the cancerous cells to grow abnormally and reduces the mortality rates of the person. Each type of cancer has its screening test, which can aid in detecting cancer in its early stages.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on the cancer types, the industry is divided into:

• Lung Cancer
• Blood Cancer
• Bone Cancer
• Gall Bladder Cancer
• Testicular Cancer
• Thyroid Cancer
• Breast Cancer
• Others

The major techniques of cancer screening are:

• Imaging Techniques
• CT Scan
• MRI
• Others
• Endoscopy
• Colonoscopy
• Sigmoidoscopy
• Others
• Biopsy and Cytology Tests
• Needle Biopsy
• CT-Guided Biopsy
• Others
• Genomic and Molecular tests
• Next Generation Sequencing (NGS)
• RT- PCR
• Others

The market can be broadly categorised on the basis of stage by:

• TNM Stages
• Stages 0, 1, 2, 3, 4
• Prognostic Factors
• Others

On the basis of gender, the market is segmented into:

• Men 
• Women

The EMR report looks into the regional markets of cancer screening like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Technological Advancements to Aid the Growth of the Cancer Screening Industry

Screening can detect cancer at an early stage, due to which the treatment can be started in the early stages, which can reduce the risk of death. The rising cases of death due to cancer is driving the market growth. Increasing research and development (R&D) to create effective treatments and early diagnosis of cancer is further propelling the market growth. Innovative technologies such as positron emission mammography, spectroscopy-enhanced colonoscopy, and hyperpolarisation MRI, among others, are increasing the efficiency of screening, consequently aiding the industry growth. Moreover, further research and innovations in the field of leukaemia and ovarian cancer, which are currently difficult to screen, are further expected to propel the industry growth in the forecast period.

The use of artificial intelligence (AI) to improve the accuracy, the speed of diagnosis, and reduce health disparity in a low-resource setting is driving the market growth. As artificial intelligence can aid clinical decision making, identify specific gene mutations, and improve MRI guided biopsy, they are used in research by various organisations, such as National Cancer Institute, which is providing further impetus to the market growth. Moreover, the use of advanced technology such as real-time data analysis, computation and digital pathology, and molecular diagnostics to enable pattern recognition in population data to predict treatment response, survival, and the likelihood of recurrence are further anticipated to aid the market growth.

Key Industry Players in the Global Cancer Screening Market

The report presents a detailed analysis of the following key players in the global cancer screening market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• DiaSorin S.p.A.
• Epigenomics AG
• Techlab, Inc.
• Positive Biosciences Limited
• MedGenome Labs Ltd
• 20/20 GeneSystems
• Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report